Medicaid Drug Pricing Final Rule Now Slated for May

by Admin | December 9, 2013 4:13 pm

December 9, 2013—The federal government is yet again postponing final regulations for the calculation of a drug’s average manufacture price (AMP) under the Medicaid drug rebate program.  


You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2013/12/medicaid-drug-pricing-final-rule-now-slated-for-may/